Pfizer remains a strong Buy with robust cost controls, EPS growth, and a promising pipeline, despite challenges. See more on ...

Pegging drug prices here to those in other countries would yield minimal savings for the United States and devastate funding ...

President Donald Trump’s proposal to peg US drug prices to those paid abroad includes granting the FDA legal authority to ...

The U.S. Department of Health and Human Services (HHS) has announced plans to enforce President Donald J. Trump’s Executive ...

We can move toward free market reforms in drug pricing. We must overturn the current perverse incentives that favor the ...

Prices of newly launched drugs in the U.S. have more than doubled from 2021 to 2024, driven by rare disease therapies, ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

U.S. President Donald Trump's trade negotiators are pushing the EU to make unilateral tariff reductions on U.S. goods, saying ...